Login to Your Account

Other News To Note

Friday, October 4, 2013

• Amarin Corp. plc, of Dublin, said it was notified by the FDA that its scheduled advisory committee meeting Oct. 16 to discuss the proposed Vascepa (icosapent ethyl) ANCHOR indication will take place as planned, despite the federal government lapse in appropriations.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription